What's Happening?
Circana, LLC has released new research indicating that households with GLP-1 medication users continue to spend more on food and beverages compared to non-user households, even as their purchasing patterns evolve beyond the first year of treatment. The
report, titled “GLP-1 Unlocked: The Next Phase of Consumer and Retail Transformation,” highlights that restaurant spending by GLP-1 households recovers in the second year of treatment, nearing pre-treatment levels. While retail food and beverage spending remained slightly below its pre-treatment baseline in Year 2, these households still outspent non-user households. The research also challenges the notion that spending on indulgent foods remains depressed, showing that candy and frozen dessert spending indices surpassed their pre-treatment baselines by Year 2. Currently, 37% of surveyed U.S. households report someone has used GLP-1 medications, up from 17% in 2024, with 30% reporting a current user.
Why It's Important?
This research is crucial for U.S. food and beverage manufacturers, retailers, and restaurants as it redefines consumer behavior among a growing segment of the population. The findings challenge initial assumptions that GLP-1 users would consistently reduce overall food spending, instead revealing a dynamic shift in purchasing habits. The recovery in restaurant spending and increased spending on indulgent categories like candy and frozen desserts by Year 2 indicates new opportunities for businesses to adapt their offerings and marketing strategies. Understanding these evolving patterns is vital for maintaining market share and developing products that cater to the changing needs and preferences of GLP-1 users. The potential for GLP-1 households to account for a significant portion of U.S. food and beverage sales by 2030 underscores the economic impact of this demographic shift.
What's Next?
Circana projects that if current adoption and spending trends persist, GLP-1 households could represent 40% of U.S. food and beverage units purchased and 41% of non-food units purchased by 2030. This projection assumes that 35% to 40% of U.S. households will have an active GLP-1 user by that time. For businesses, the immediate next steps involve closely monitoring these evolving consumer behaviors and adjusting product development, marketing, and retail strategies accordingly. There is an opportunity for brands to innovate and offer products that align with the changing dietary needs and preferences of GLP-1 users, including those who may restart treatment, as 48% of surveyed previous-user households are likely to do so within the next year. This ongoing evolution necessitates continuous adaptation from the industry.
Beyond the Headlines
The deeper implications of this research extend to the broader understanding of consumer psychology and health-related purchasing decisions. The initial assumption that GLP-1 users would simply 'buy less' overlooked the complex process of behavioral adjustment and the potential for new needs to emerge. This highlights a shift in how health-related interventions can influence not just individual consumption but also broader market dynamics. The data suggests that consumers, even while managing health conditions, still seek enjoyment and variety in their food choices, leading to a 'consumer reset' rather than a permanent reduction in spending. This could lead to a re-evaluation of how the food industry approaches health-conscious consumers, moving beyond simple calorie reduction to a more holistic understanding of evolving dietary patterns and preferences.
